Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 27, 2015 2:21 AM ET

Biotechnology

Company Overview of Acceleron Pharma, Inc.

Company Overview

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. The company is developing luspatercept and sotatercept therapeutic candidates, which are in Phase 3 clinical trials used to treat anemia and associated complications in patients with ß-thalassemia and myelodysplastic syndromes. The sotatercept therapeutic candidate is also used to increase bone mineral density; and to treat the final stage of chronic kidney disease and end-stage renal disease. It is also developing dalantercept therapeutic candidate to treat renal cell carcinoma and hepatocellular carcinoma; and ...

128 Sidney Street

Cambridge, MA 02139

United States

Founded in 2003

83 Employees

Phone:

617-649-9200

Fax:

617-649-9988

Key Executives for Acceleron Pharma, Inc.

Founder, Chief Executive Officer, President and Director
Age: 62
Total Annual Compensation: $460.0K
Chief Financial Officer, Senior Vice President and Treasurer
Age: 58
Total Annual Compensation: $325.0K
Chief Operating Officer and Executive Vice President
Age: 45
Total Annual Compensation: $335.0K
Chief Medical Officer and Executive Vice President
Age: 58
Total Annual Compensation: $392.0K
Senior Vice President, General Counsel and Secretary
Age: 43
Total Annual Compensation: $335.0K
Compensation as of Fiscal Year 2014.

Acceleron Pharma, Inc. Key Developments

Acceleron Pharma Inc. Appoints Francois Nader as Chairman of its Board of Directors

Acceleron Pharma Inc. announced the appointment of Francois Nader, M.D., M.B.A, as the chairman of its board of directors. Dr. Nader joined the company's board in December 2014.

Acceleron Pharma, Inc. Announces Executive Changes

Acceleron Pharma Inc. announced two executive promotions and appointments from within the organization. Steven Ertel has been named executive vice president and chief operating officer, he previously held the title of senior vice president and chief business officer. Matthew L. Sherman, M.D., has been promoted to executive vice president and chief medical officer.

Acceleron Pharma Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014

Acceleron Pharma Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, collaboration revenue was $3.7 million against $11.5 million last year. Loss from operations was $14.6 million against $3.5 million last year. Net loss applicable to common stockholders was $17.6 million or $0.55 per basic and diluted share against $18.1 million or $0.64 per basic and diluted share last year. For the year, collaboration revenue was $14.6 million against $57.2 million last year. Loss from operations was $55.5 million against income from operations of $7 million last year. Net loss applicable to common stockholders was $51.3 million or $1.63 per basic and diluted share against $39.0 million or $4.15 per basic and diluted share last year.

Similar Private Companies By Industry

Company Name Region
Amnestix Inc. United States
Nutraceutical Research Innovations LLC United States
LipoScience, Inc. United States
Alacritas Biopharma, Inc. United States
LifeGen Technologies LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Acceleron Pharma, Inc., please visit www.acceleronpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.